Evaluation and Management of Neuroendocrine Tumors of the Pancreas
Surgical Clinics of North America, ISSN: 0039-6109, Vol: 99, Issue: 4, Page: 793-814
2019
- 83Citations
- 148Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations83
- Citation Indexes82
- 82
- CrossRef73
- Policy Citations1
- Policy Citation1
- Captures148
- Readers148
- 148
Review Description
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. Although they exhibit indolent growth, metastases are seen in roughly 60% of patients. Pancreatic neuroendocrine tumors may produce a wide variety of hormones, which are associated with dramatic symptoms, but the majority are nonfunctional. The diagnosis and treatment of these tumors is a multidisciplinary effort, and management guidelines continue to evolve. This review provides a concise summary of the presentation, diagnosis, surgical management, and systemic treatment of pancreatic neuroendocrine tumors.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0039610919300404; http://dx.doi.org/10.1016/j.suc.2019.04.014; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85066096834&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/31255207; https://linkinghub.elsevier.com/retrieve/pii/S0039610919300404; https://dx.doi.org/10.1016/j.suc.2019.04.014
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know